ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
Pharmatech Teams Up With Systems Medicine LLC And The Sarcoma Foundation Of America For A Phase II Myxoid Liposarcoma Trial
Pharmatech, Inc., a Research Management
Organization (RMO), has contracted with Systems Medicine LLC (SML), a
subsidiary of Seattle-based Cell Therapeutics, Inc. (CTI), to provide
research and site management services for their phase II open-label
clinical study for patients with myxoid liposarcoma with a (12;16)
translocation. The study is intended to assess the safety and efficacy of
SML's experimental drug product, brostallicin. The trial will also be
supported by the Sarcoma Foundation of America (SFA).
Pharmatech will manage this sarcoma trial using its innovative
Just-In-Time(TM) (JIT) approach. This streamlined approach was created to
increase enrollment in clinical trials for rare cancer disease indications
with narrow patient populations. The study sponsor does not open the trial
at the site level until a potential patient is identified through basic
standard of care procedures, thus saving time, money, and effort for both
the sites and the sponsors. Patient enrollment, through Just-In-Time, is
further increased because a protocol can be rolled out to a large number of
qualified Research Network sites with minimal expense of time and capital.
The SML trial allowed for the formation of a partnership between
Pharmatech and the Sarcoma Foundation of America. The union of the two
organizations helps create awareness for the Foundation's Sarcoma Patient
Registry program. The Registry allows patients to call into the Foundation
to sign up for participation in the Registry program. If they consent, then
they are notified by the Foundation if a current or future trial fits their
specific disease indications. Matthew Alsante, Executive Director, Sarcoma
Foundation of America, states, "The collaboration allows for a superior
coordination among key players in the clinical trial process. The patients
come to the Foundation through our sophisticated Registry. The Foundation
takes the incidence data from the Registry to communicate directly with the
patients about the clinical trials available to them through partnerships
with research management groups such as Pharmatech."
About Pharmatech, Inc.
Pharmatech, headquartered in Denver, Colorado, is a Research Management
Organization (RMO) dedicated to the highest quality of clinical research,
while protecting patient safety. Pharmatech provides services of a Site
Management Organization (SMO) and a Contract Research Organization (CRO)
with a focus in oncology clinical trials. Through organized research
networks, the Company focuses on access to clinical trials for patients and
clinical investigators. The Network model provides a foundation for the
development and utilization of therapeutic products among sponsors,
investigators, and patients. For more information about Pharmatech, please
visit http://www.pharmatech.com.
About Systems Medicine LLC
Systems Medicine, LLC (SML), develops oncology products by integrating
predictive cellular pharmacogenomics ("genomics") with world-class clinical
and regulatory expertise. This allows SML to develop patient-selective
therapies by defining the context of vulnerability of cancer and treating
only those patients most likely to respond to specific drugs or drug
combinations. For more information on SML and the products that SML has in
development, please visit http://www.systems-medicine.com.
About the Sarcoma Foundation of America
The mission of the Sarcoma Foundation is to act as an advocate for
increased research to find new and better therapies with which to treat
patients with sarcoma. The Foundation has created a Sarcoma Patient
Registry program that has the capability to match sarcoma patients into
corresponding clinical trials. Please visit their website at
http://www.curesarcoma.org for more information on the programs they have
in place to help sarcoma patients.
Pharmatech, Inc.
http://www.pharmatech.com
Pharmatech echipe cu sisteme de Medicina "SRL ºi a Fundaþiei sarcom din America, pentru un studiu de faza II Myxoid Liposarcoma proces - Pharmatech Teams Up With Systems Medicine LLC And The Sarcoma Foundation Of America For A Phase II Myxoid Liposarcoma Trial - articole medicale engleza - startsanatate